PL02.06 First-Line Osimertinib + Chemotherapy Versus Osimertinib Monotherapy in EGFRm Advanced NSCLC: FLAURA2 Final Overall Survival
D. Planchard,
P.A. Jänne,
K. Kobayashi,
J.C.-H. Yang,
Y. Liu,
Natalia Valdiviezo,
T.M. Kim,
Lingxiang Jiang,
H. Kagamu,
N. Yanagitani,
Journal of Thoracic Oncology · 2025 · 10 citations · 0 references